Skip to main content
AMGN
NASDAQ Life Sciences

Judge Blocks Colorado's Enbrel Price Cap, Protecting Amgen's Blockbuster Drug Revenue

Tom Rudovsky · Reported by Reuters
More coverage: Pharmaceutical Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$361.33
Mkt Cap
$195.013B
52W Low
$269.77
52W High
$391.29
52W Position info
34% above low
Off High info
7.7% below high
Rel. Volume info
0.8× avg
Market data snapshot near publication time

AMGN sits 34% above its 52-week low of $269.77.

Summary

A federal judge has blocked Colorado's attempt to cap the price of Amgen's blockbuster arthritis drug, Enbrel. This ruling prevents a first-of-its-kind state-level price cap that would have limited Enbrel's annual cost to $31,200, significantly below its current list price exceeding $100,000. The decision protects a major revenue stream for Amgen, as Enbrel generated $2.23 billion in sales in 2025. This outcome is a significant win for Amgen, potentially preventing similar price control measures in other states and safeguarding the company's drug pricing power.

At the time of this announcement, AMGN was trading at $361.33 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $195B. The 52-week trading range was $269.77 to $391.29. This news item was assessed with positive market sentiment and an importance score of 8 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

AMGN - Latest Insights

AMGN
Nov 05, 2026, 3:00 AM EST
Source: Wiseek News
Importance Score:
8
Price at Filing: $477.40
Real-time Price: $446.87 info
Change: -$30.54 (-6%) info
Market Cap: $241.714B info
AMGN
Nov 03, 2026, 6:37 PM EST
Filing Type: 10-Q
Importance Score:
7
Price at Filing: $464.92
Real-time Price: $446.87 info
Change: -$18.06 (-4%) info
Market Cap: $241.714B info
AMGN
Nov 03, 2026, 4:05 PM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $463.00
Real-time Price: $446.87 info
Change: -$16.13 (-3%) info
Market Cap: $241.714B info
AMGN
Nov 03, 2026, 4:01 PM EST
Source: Dow Jones Newswires
Importance Score:
7
Price at Filing: $460.57
Real-time Price: $446.87 info
Change: -$13.70 (-3%) info
Market Cap: $241.714B info
AMGN
Oct 26, 2026, 9:23 AM EDT
Source: Benzinga
Importance Score:
7
Price at Filing: $448.79
Real-time Price: $446.87 info
Change: -$1.93 (-0.43%) info
Market Cap: $241.714B info